Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
New research explores how microvascular dysfunction and nerve signaling disruption cause silent myocardial ischemia in diabetic patients—without warning symptoms.
By Peptide Association Research Team
New research links perioperative opioid use to hippocampal mitochondrial dysfunction and lasting cognitive impairment in aged rats. What does it mean for patients?
By Peptide Association Research Team
New research in aged rats suggests opioid use after surgery disrupts hippocampal mitochondria, contributing to long-term cognitive decline. Learn what the findings mean.
By Peptide Association Research Team
New research links perioperative opioid use to hippocampal mitochondrial dysfunction in aged rats, suggesting a potential target for treating postoperative cognitive decline.
By Peptide Association Research Team
New research links perioperative opioid use to hippocampal mitochondrial dysfunction and cognitive decline in aged rats. Learn what the findings mean for patients.
By Peptide Association Research Team
New research explores repurposed drugs targeting Alzheimer's disease pathways. Learn what the latest evidence suggests about emerging therapeutic strategies.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction affects female fertility and which therapeutic strategies may help restore ovarian function. Learn what the science says.
By Peptide Association Research Team
A 2026 study in Biogerontology suggests GHK-Cu may delay aging by supporting mitochondrial function and activating key longevity pathways. Learn what the research shows.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by protecting mitochondria and reducing cell death. Learn what the study found.
By Peptide Association Research Team
New research on SS-31 peptide-loaded liposomes suggests potential for targeting mitochondrial function in fat cells. Study shows promising results in animal models.
By Peptide Association Research Team
New research on mitochondria-targeted liposomes with SS-31 peptide demonstrates potential for enhancing thermogenesis in adipose tissue studies.
By Peptide Association Research Team